[{"address1": "7750 El Camino Real", "address2": "Suite 2A", "city": "Carlsbad", "state": "CA", "zip": "92009", "country": "United States", "phone": "858 704 4900", "website": "https://www.palisadebio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the intestinal barrier in the United States. The company's lead therapeutic candidate is PALI-2108, a prodrug PDE4 inhibitor, currently under pre-clinical development as a therapeutic for patients living with inflammatory bowel diseases, including ulcerative colitis and Crohn's disease (CD), as well as develops PALI-1908, an oral, selective PDE4 inhibitor prodrug that is locally bioactivated in the terminal ileum of CD patients, currently in the research stage. It has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; a license agreement with the Regents of the University of California; a co-development and distribution agreement with Newsoara Biopharma Co., Ltd; and a transformative strategic collaboration with Strand Life Sciences for advancing precision medicine for ulcerative colitis therapy. The company is based in Carlsbad, California.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Dr. Joerg  Heyer Ph.D.", "title": "Head of Translational Science & Medicine", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryker  Willie", "title": "Senior VP of Finance & Corporate Controller", "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.6895, "open": 0.6864, "dayLow": 0.675, "dayHigh": 0.7, "regularMarketPreviousClose": 0.6895, "regularMarketOpen": 0.6864, "regularMarketDayLow": 0.675, "regularMarketDayHigh": 0.7, "payoutRatio": 0.0, "beta": 1.41, "forwardPE": -0.07551535, "volume": 24077, "regularMarketVolume": 24077, "averageVolume": 587057, "averageVolume10days": 142940, "averageDailyVolume10Day": 142940, "bid": 0.6456, "ask": 0.7452, "bidSize": 1, "askSize": 1, "marketCap": 2042670, "fiftyTwoWeekLow": 0.65, "fiftyTwoWeekHigh": 9.65, "fiftyDayAverage": 1.055, "twoHundredDayAverage": 2.7246, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -6634030, "profitMargins": 0.0, "floatShares": 4088969, "sharesOutstanding": 2765980, "sharesShort": 291489, "sharesShortPriorMonth": 106913, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0983, "heldPercentInsiders": 0.00506, "heldPercentInstitutions": 0.04531, "shortRatio": 0.43, "shortPercentOfFloat": 0.1058, "impliedSharesOutstanding": 2945070, "bookValue": 2.705, "priceToBook": 0.2546026, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -14438000, "trailingEps": -10.19, "forwardEps": -9.12, "lastSplitFactor": "1:15", "lastSplitDate": 1712534400, "enterpriseToEbitda": 0.447, "52WeekChange": -0.8820513, "SandP52WeekChange": 0.06429911, "quoteType": "EQUITY", "currentPrice": 0.6887, "targetHighPrice": 38.0, "targetLowPrice": 2.0, "targetMeanPrice": 18.0, "targetMedianPrice": 14.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 9833000, "totalCashPerShare": 2.236, "ebitda": -14856000, "totalDebt": 169000, "quickRatio": 3.046, "currentRatio": 3.243, "debtToEquity": 2.256, "returnOnAssets": -0.74498004, "returnOnEquity": -1.5355499, "freeCashflow": -7644375, "operatingCashflow": -12193000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PALI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NCM", "messageBoardId": "finmb_244367385", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Palisade Bio, Inc.", "corporateActions": [], "postMarketTime": 1743204752, "regularMarketTime": 1743192000, "fiftyDayAverageChange": -0.36629993, "fiftyDayAverageChangePercent": -0.34720373, "twoHundredDayAverageChange": -2.0359, "twoHundredDayAverageChangePercent": -0.747229, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "marketState": "CLOSED", "regularMarketChangePercent": -0.11601943, "regularMarketPrice": 0.6887, "longName": "Palisade Bio, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1175261400000, "postMarketChangePercent": -0.174244, "postMarketPrice": 0.6875, "postMarketChange": -0.00120002, "regularMarketChange": -0.00079995394, "regularMarketDayRange": "0.675 - 0.7", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 587057, "fiftyTwoWeekLowChange": 0.038700044, "fiftyTwoWeekLowChangePercent": 0.059538532, "fiftyTwoWeekRange": "0.65 - 9.65", "fiftyTwoWeekHighChange": -8.9613, "fiftyTwoWeekHighChangePercent": -0.92863214, "fiftyTwoWeekChangePercent": -88.20513, "dividendDate": 1563408000, "earningsTimestamp": 1742846400, "earningsTimestampStart": 1747053000, "earningsTimestampEnd": 1747398600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -10.19, "epsForward": -9.12, "epsCurrentYear": -2.37, "priceEpsCurrentYear": -0.29059073, "displayName": "Palisade Bio", "trailingPegRatio": null, "__fetch_time": "2025-03-29"}]